abstract |
The present invention provides a compound of formula (I): (See Formula) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, A1, A2, A3, A4, L, B1, B2, B3 and B4 they are as defined in this document; it has been found that the compounds of formula I act as glucagon antagonists or inverse agonists; consequently, the compounds of formula I and the pharmaceutical compositions thereof are useful for the treatment of glucagon-mediated diseases, disorders or conditions. |